CareLit · DOI-Nachweis · Aktuelle Neurologie
Clinical Trial: Efficacy and Tolerability of Entacapone versus Cabergoline in Elderly Parkinsonian Patients with Fluctuations
DOI 10.1055/s-2006-953158
Bibliografische Angaben
Nachweis in CareLit
Autor:innenG. Deuschl, G.C. Fox, T. Roscher, D. Schremmer
ZeitschriftAktuelle Neurologie
Ausgabe09/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
for the CAMP Study Group Objective: To investigate benefits and drawbacks of entacapone (ENT) and cabergoline (CBG) as adjuncts to Levodopa (LD) in elderly patients (pts) with Parkinson's disease (PD) suffering from wearing-off. Aims: Long-term LD therapy is associated with the emergence of motor complications, such as fluctuations and dyskinesias. The guidelines of the German Society of Neurology for the treatment…
Zitieren
Zitierempfehlung
G. Deuschl, G.C. Fox, T. Roscher, D. Schremmer (2006) Clinical Trial: Efficacy and Tolerability of Entacapone versus Cabergoline in Elderly Parkinsonian Patients with Fluctuations. Aktuelle Neurologie (09). https://doi.org/10.1055/s-2006-953158
Mit CareLit weiterarbeiten